Several genetic mouse models of pancreatic cancer have been developed [49] and in this study, we used mice with p53 mutations and overexpression of activated Kras in the pancreas since they rapidly develop pancreatic tumors that resemble human PDAC [47]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.